NLRP6 and liver disorder: Although the loss of NLRP6 NEMO other IKK components have not been described in human HCC, this mouse model nicely reflects essential mechanisms of human liver disease progression and allowed us to study the impact of intestinal dysbiosis induced by loss of NLRP6 on liver disease progression.